NEWS

/ NEWS / Axim Biotechnologies Goes With Grayling

Latest news from Grayling

Axim Biotechnologies Goes With Grayling

7th November 2016


Innovative biotechnology company, Axim Biotechnologies Inc has appointed Grayling in the US to support its Investor Relations and Public Relations’ needs.

Axim Biotechnologies is engaged in the research and development, and production of pharmaceutical, nutriceutical and cosmetic products, as well as the procurement of genetically and nano-controlled active ingredients. The company’s particular focus is on the development of treatments for pain, spasticity, anxiety and other medical disorders using cannabinoids-based products. Pharmaceutical R&D aims to deliver systems and active pharmaceutical ingredients for treating conditions such as Parkinson's disease, Alzheimer's disease, restless leg syndrome and Crohn's disease.

Presently, the company is conducting clinical studies of MedChewRx, a pharmaceutical chewing gum containing cannabinoids. The company is in the process of getting FDA and EMA regulatory approval to launch this product in 2017, and it is in regard to this that Grayling is providing support.

Grayling’s efforts will be driven by New York based executive vice president, Lucia Domville. She says: “This is a fascinating company that is really pushing the boundaries with its research, and we are thrilled to be their partner.”


Grayling Team

Latest News

14th September 2017


Grayling named finalist in PR News' Digital Awards for work with VAIO

Grayling has been named a finalist in PR News’ Digital Awards in the category Locations-Based Digital for Grayling's Taking a Bite out of the Big Apple campaign on behalf of VAIO. In addition to...

Read More

7th August 2017


Grayling's Meakin to talk innovation at international comms summit

Grayling's global head of strategic services, Jon Meakin will join a roster of international speakers at the ICCO Global Summit, to be held in Helsinki on 5-6 October. With a theme of...

Read More

5th August 2017


Grayling Supports Post-IPO Bank

Grayling has been appointed by a leading Mexican bank with its post-IPO communications with investors. BanBajio, or Banco del Bajio, is the third largest bank locally-controlled bank in Mexico and in...

Read More